Significance of PTPRZ1 and CIN85 expression in cervical carcinoma

Archives of Gynecology and Obstetrics

Volumn 284, Issue 3, 2011, Pages 699-704

  Ma, Yaxi ^a   Ye, Feng ^a   Xie, Xing ^a   Zhou, Caiyun ^a   Lu, Weiguo ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cervical carcinoma; CIN85; Gynae oncology; PTPRZ1

Indexed keywords

85 KDA CBL INTERACTING PROTEIN; CBL PROTEIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE Z POLYPEPTIDE 1; UNCLASSIFIED DRUG; PTPRZ1 PROTEIN, HUMAN; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SH3KBP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PELVIS LYMPHADENECTOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA; UTERINE CERVIX EPITHELIUM; UTERUS MYOMA; METABOLISM; MIDDLE AGED; NONPARAMETRIC TEST; PATHOLOGY; UTERINE CERVIX TUMOR;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 5; STATISTICS, NONPARAMETRIC; TUMOR BURDEN; UTERINE CERVICAL NEOPLASMS;

EID: 84855985178     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-010-1693-9     Document Type: Article

References (24)

1. Barnea G, Grumet M, Milev P, Silvennoinen O, Levy JB, Sap J et al (1994) Receptor tyrosine phosphatase β expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J Biol Chem 269(20):14349-14352 (Pubitemid 24193978)
2. Yamakawa T, Kurosawa N, Kadomatsu K, Matsui T, Itoh K, Maeda N (1999) Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers. Cancer Lett 135(1):91-96 (Pubitemid 29069070)
3. Foehr ED, Lorente G, Kuo J, Ram R, Nikolich K, Urfer R (2006) Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res 66(4):2271-2278
4. Wu CW, Kao HL, Li AF, Chi CW, Lin WC (2006) Protein tyrosine-phosphatase expression profiling in gastric cancer tissues. Cancer Lett 242(1):95-103 (Pubitemid 44485295)
5. Goldmann T, Otto F, Vollmer E (2000) A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas. Folia Histochem Cytobiol 38(1):19-20 (Pubitemid 30063966)
6. Ulbricht U, Brockmann MA, Aigner A, Eckerich C, Müller S, Fillbrandt R et al (2003) Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J Neuropathol Exp Neurol 62(12):1265-1275 (Pubitemid 37494195)
7. Dikic I (2002) CIN85/CMS family of adaptor molecules. FEBS Lett 529(1):110-115 (review) (Pubitemid 35283919)
8. Dikic I, Giordano S (2003) Negative receptor signalling. Curr Opin Cell Biol 15(2):128-135 (review) (Pubitemid 36332186)
9. Szymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S, Dikic I (2002) CIN85 participates in Cbl-b-mediated downregulation of receptor tyrosine kinases. J Biol Chem 277(42):39666-39672 (Pubitemid 35190948)
10. Bögler O, Furnari FB, Kindler-Roehrborn A, Sykes VW, Yung R, Huang HJ et al (2000) SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes. Neuro Oncol 2(1):6-15
11. Mayevska O, Shuvayeva H, Igumentseva N, Havrylov S, Basaraba O, Bobak Y et al (2006) Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Exp Oncol 28(4):275-281 (Pubitemid 46226097)
12. Havrylov S, Rzhepetskyy Y, Malinowska A, Drobot L, Redowicz MJ (2009) Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS. Proteome Sci 7(1):21
13. Petereit DG, Eifel PJ, Thomas GM (2007) Cervical cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 2nd edn. Churchill Livingstone, Philadelphia, pp 1323-1357
14. Gadducci A, Teti G, Barsotti C, Tana R, Fanucchi A, Orlandini C et al (2010) Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Anticancer Res 30(1):201-208
15. Meng K, Rodriguez-Peña A, Dimitrov T, Chen W, Yamin M, Noda M et al (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA 97(6):2603-2608 (Pubitemid 30159217)
16. Wu M, Gan K, Huang C, Tang Y, Chen Q, Tang K et al (2006) LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression. J Neurooncol 80(2):133-142 (Pubitemid 44614793)
17. Nagata S, Saito R, Yamada Y, Fujita N, Watanabe K (2001) Multiple variants of receptor-type protein tyrosine phosphatase beta are expressed in the central nervous system of Xenopus. Gene 262(1-2):81-88 (Pubitemid 32155337)
18. Levy JB, Canoll PD, Silvennoinen O, Barnea G, Morse B, Honegger AM et al (1993) The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J Biol Chem 268(14):10573-10581 (Pubitemid 23150247)
19. Lorente G, Nelson A, Mueller S, Kuo J, Urfer R, Nikolich K et al (2005) Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment. Neuro Oncol 7(2):154-163 (Pubitemid 40590515)
20. Ulbricht U, Eckerich C, Fillbrandt R, Westphal M, Lamszus K (2006) RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo. J Neurochem 98(5):1497-1506 (Pubitemid 44200441)
21. Lu KV, Jong KA, Kim GY, Singh J, Dia EQ, Yoshimoto K et al (2005) Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J Biol Chem 280(29):26953-26964 (Pubitemid 41040731)
22. Perez-Pinera P, Garcia-Suarez O, Menendez-Rodriguez P, Mortimer J, Chang Y, Astudillo A et al (2007) The receptor protein tyrosine phosphatase (RPTP) beta/zeta is expressed in different subtypes of human breast cancer. Biochem Biophys Res Commun 362(1):5-10 (Pubitemid 47296285)
23. Nam JM, Onodera Y, Mazaki Y, Miyoshi H, Hashimoto S, Sabe H (2007) CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J 26(3):647-656
24. Gaidos G, Soni S, Oswald DJ, Toselli PA, Kirsch KH (2007) Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic-complex formation. J Cell Sci 120(14):2366-2377 (Pubitemid 47225940)